Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

BACKGROUND: Addition of gemcitabine and cisplatin (GP) or docetaxel and cisplatin plus fluorouracil (TPF) to concurrent chemoradiotherapy (CCRT) significantly improved survival in locoregionally advanced nasopharyngeal carcinoma (NPC). However, an economic evaluation of these regimens remains unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiangping, Han, Jiaqi, He, Jinlan, Duan, Baofeng, Gou, Qiheng, Ai, Ping, Liu, Lei, Li, Yanchu, Ren, Kexing, Wang, Feng, Yao, Min, Chen, Nianyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786365/
https://www.ncbi.nlm.nih.gov/pubmed/33425747
http://dx.doi.org/10.3389/fonc.2020.594756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786365/
https://www.ncbi.nlm.nih.gov/pubmed/33425747
http://dx.doi.org/10.3389/fonc.2020.594756

Ejemplares similares